Amwell announced it has closed its Series C financing round, adding $194 million in funding. Many early investors and strategic partners participated in this round, including Allianz X and Takeda. Amwell will use significant parts of the funds to expand its investment in technology and services that make it easy, convenient, and effective for clinical professionals and consumers to connect securely at scale. Amwell will continue to ensure that clinical encounters remain fully integrated in existing workflows and enveloped with healthcare-appropriate clinical and administrative information, management, and reporting.

As a result of the COVID-19 pandemic, Amwell has seen . . .

Want To Read More? Log In Or Become A Free Member
Resource Available For All OPEN MINDS Circle Members
If you are already a member, log in to your account to access this resource and more.

You can become a free member and get access now. Learn more about the OPEN MINDS Circle Market Intelligence Service Membership. Reach out to our team at info@openminds.com, or call us at 877-350-6463.

A Paid OPEN MINDS Circle Membership provides unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!